In one paragraphArticle in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Pablo Garcia-AceroIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.ORCID 0000-0001-5844-4892 Ismael Henarejos-CastilloIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.
Francisco Jose SanzIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.
Patricia Sebastian-LeonIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.ORCID 0000-0001-7299-3660 Antonio Parraga-LeoIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.ORCID 0000-0001-9496-6989 Juan Antonio Garcia-VelascoIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.ORCID 0000-0003-1005-8727 Patricia Diaz-GimenoIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe, Av. Fernando Abril Martorell 106, Torre A, Planta 1, 46026 Valencia, Spain.ORCID 0000-0003-0031-7545 Funding
Generalitat Valenciana ACIF/2019/047Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Science and Innovation) and co-funded by the European Regional Development Fund "A way to make Europe" CD21/00132Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Science and Innovation) and co-funded by the European Regional Development Fund "A way to make Europe" CD23/00032Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Science and Innovation) and co-funded by the European Regional Development Fund "A way to make Europe" CP20/00118Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Science and Innovation) and co-funded by the European Regional Development Fund "A way to make Europe" FI20/00085Instituto de Salud Carlos III (ISCIII) (Spanish Ministry of Science and Innovation) and co-funded by the European Regional Development Fund "A way to make Europe" PI19/00537IVI Foundation Research Department 1706-FIVI-048-PDSpanish Ministry of Science, Innovation, and Universities FPU/18/01777
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
drug–drug interactionsfemale reproductive therapiesgynecologypharmacotherapypolypharmacologyside effects
Identifiers
PMID40871041
PMCPMC12389331
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390